UK's NICE Recommends Genetic Testing for Therapy Selection in Stroke Patients
Clopidogrel is less effective at preventing subsequent strokes in patients with certain variations in the CYP2C19 gene and testing could aid treatment selection.
United Kingdom Mark Chapman United Kingdom Department Of Health United Kingdom National Institute For Health Implementation Consortium United Kingdom National Institute
Source: 360dx.com